Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

Biotechnology

Healthcare
$10.19 -1.58%

-$0.19 today

Market cap
$859.56M
Beta
0.84
P/E (TTM)
-24.1
EPS (TTM)
-$0.49
52W Low $3.55High $26.95

Volume 0.99M

Average 1.49M

Balance Sheet

Inspect the capital base behind the business.

Assets

$71.12M

FY 2025 · Annual

+3.2% YoY

Liabilities

$9.91M

FY 2025 · Annual

-72.7% YoY

Equity

$61.20M

FY 2025 · Annual

+87.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents63.46M13.16M12.62M8.74M4.58M
Short-term Investments5.99M29.14M14.53M43.22M52.17M
Net Receivables539K633K63K216K374K
Inventory00000
Other Current Assets128K102K220K548K318K
Total Current Assets71.31M43.66M27.96M54.41M58.21M
Property, Plant & Equipment (Net)3.64M2.57M1.39M1.33M1.06M
Goodwill00000
Intangible Assets00000
Long-term Investments34.27M21.88M16.12M12.54M10.99M
Tax Assets00000
Other Non-current Assets236K129K89K632K855K
Total Non-current Assets38.14M24.58M17.6M14.5M12.91M
Total Assets109.46M68.24M45.55M68.91M71.12M
Account Payables1.57M1.98M1.53M2.58M2.49M
Short-term Debt0000403K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.97M1.27M929K30.02M5.85M
Total Current Liabilities9.69M10.75M6.87M35.4M9.38M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities2.6M1.37M0937K534K
Total Liabilities12.29M12.13M6.87M36.34M9.91M
Common Stock5K5K5K7K7K
Retained Earnings(266.38M)(307.69M)(334.72M)(397.01M)(412.29M)
Accumulated OCI1.87M(563K)(967K)(1.29M)(896K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity97.16M56.12M38.68M32.57M61.21M
Total Debt3.65M2.6M1.37M1.12M937K
Net Debt(59.81M)(10.56M)(11.25M)(7.62M)(3.64M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$40.1M
Short-term Investments$196.6M
Receivables$1.2M
Other Current$2.0M
Total Current Assets$239.9M
PP&E (Net)$1.0M
Long-term Investments$10.5M
Other Non-current$1.7M
Total Non-current Assets$13.2M
Total Assets$253.2M

Analysis

Selected assets total $253.2M for Latest. The largest visible component is Short-term Investments at $196.6M, about 77.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13GSC 13G filingAug 7, 2026

How much cash does CRVS have?

Corvus Pharmaceuticals, Inc. (CRVS) reported $4.58M in cash and equivalents in fiscal 2025.

How much debt does CRVS carry?

Corvus Pharmaceuticals, Inc. (CRVS) reported $937,000.00 of total debt, with net debt of -$3.64M.